Germline mutations 657del5 and 643C>T (R215W) in NBN are not likely to be associated with increased risk of breast cancer in Czech women

Breast Cancer Research and Treatment

Volumn 133, Issue 2, 2012, Pages 809-811

  Mateju, Martin ^a   Kleiblova, Petra ^b   Kleibl, Zdenek ^b   Janatova, Marketa ^b   Soukupova, Jana ^b   Ticha, Ivana ^b,c   Novotny, Jan ^a   Pohlreich, Petr ^b  

^a CHARLES UNIVERSITY   (Czech Republic)

^b CHARLES UNIVERSITY   (Czech Republic)

^c LINKÖPING UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

DNA;

BREAST CANCER; CANCER RISK; CANCER SUSCEPTIBILITY; CONTROLLED STUDY; CZECH REPUBLIC; DNA DETERMINATION; FEMALE; GENE; GENE MUTATION; GENETIC ASSOCIATION; HETEROZYGOTE; HUMAN; LETTER; MAJOR CLINICAL STUDY; NBN GENE; OVARY CANCER; PRIORITY JOURNAL; RISK ASSESSMENT;

BREAST NEOPLASMS; CELL CYCLE PROTEINS; CZECH REPUBLIC; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GERM-LINE MUTATION; HUMANS; NUCLEAR PROTEINS; RISK FACTORS;

EID: 84863716568     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-012-2049-x     Document Type: Letter

References (11)

1. Varon R, Vissinga C, Platzer M, Cerosaletti KM, Chrzanowska KH, Saar K, Beckmann G, Seemanová E, Cooper PR, Nowak NJ, Stumm M, Weemaes CM, Gatti RA, Wilson RK, Digweed M, Rosenthal A, Sperling K, Concannon P, Reis A (1998) Nibrin, a novel DNA double-strand break repair protein, is mutated in Nijmegen breakage syndrome. Cell 93:467-476
2. Varon R, Seemanova E, Chrzanowska K, Hnateyko O, Pie-kutowska-Abramczuk D, Krajewska-Walasek M, Sykut-Ce-gielska J, Sperling K, Reis A (2000) Clinical ascertainment of Nijmegen breakage syndrome (NBS) and prevalence of the major mutation, 657del5, in three Slav populations. Eur J Hum Genet 8:900-902
3. Maurer MH, Hoffmann K, Sperling K, Varon R (2010) High prevalence of the NBN gene mutation c.657-661del5 in Southeast Germany. J Appl Genet 51:211-214
4. di Masi A, Antoccia A (2008) NBS1 heterozygosity and cancer risk. Curr Genomics 9:275-281
5. Gorski B, Debniak T, Masojc B, Mierzejewski M, Medrek K, Cybulski C, Jakubowska A, Kurzawski G, Chosia M, Scott R, Lubinski J (2003) Germline 657del5 mutation in the NBS1 gene in breast cancer patients. Int J Cancer 106:379-381
6. Steffen J, Nowakowska D, Niwinska A, Czapczak D, Kluska A, Piatkowska M, Wisniewska A, Paszko Z (2006) Germline mutations 657del5 of the NBS1 gene contribute significantly to the incidence of breast cancer in Central Poland. Int J Cancer 119:47-472
7. Bogdanova N, Feshchenko S, Schurmann P, Waltes R, Wieland B, Hillemanns P, Rogov YI, Dammann O, Bremer M, Karstens JH, Sohn C, Varon R, Dörk T (2008) Nijmegen breakage syndrome mutations and risk of breast cancer. Int J Cancer 122:802-806
8. Carlomagno F, Chang-Claude J, Dunning AM, Ponder BA (1999) Determination of the frequency of the common 657del5 Nijmegen breakage syndrome mutation in the German population: no association with risk of breast cancer. Genes Chromosomes Cancer 25:393-395
9. He M, Di GH, Cao AY, Hu Z, Jin W, Shen ZZ, Shao ZM (2011) RAD50 and NBS1 are not likely to be susceptibility genes in Chinese non-BRCA1/2 hereditary breast cancer. Breast Cancer Res Treat. doi:10.1007/s10549-011-1700-2
10. Pohlreich P, Zikan M, Stribrna J, Kleibl Z, Janatova M, Kotlas J, Zidovska J, Novotny J, Petruzelka L, Szabo C, Matous B (2005) High proportion of recurrent germline mutations in the BRCA1 gene in breast and ovarian cancer patients from the Prague area. Breast Cancer Res 7:R728-R736
11. Kleibl Z, Havranek O, Novotny J, Kleiblova P, Soucek P, Pohlreich P (2008) Analysis of CHEK2 FHA domain in Czech patients with sporadic breast cancer revealed distinct rare genetic alterations. Breast Cancer Res Treat 112:159-164